NM_000455.5(STK11):c.1014G>A (p.Val338=) AND Hereditary cancer-predisposing syndrome

Germline classification:: Likely benign (2 submissions)
Last evaluated:: Mar 30, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003585834.2

Allele description [Variation Report for NM_000455.5(STK11):c.1014G>A (p.Val338=)]

NM_000455.5(STK11):c.1014G>A (p.Val338=)

Genes:

LOC130062899:ATAC-STARR-seq lymphoblastoid active region 13597 [Gene]
STK11:serine/threonine kinase 11 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

19p13.3

Genomic location:

Preferred name:

NM_000455.5(STK11):c.1014G>A (p.Val338=)

HGVS:

NC_000019.10:g.1223078G>A
NG_007460.2:g.38672G>A
NG_197316.1:g.133G>A
NM_000455.5:c.1014G>AMANE SELECT
NM_001407255.1:c.1014G>A
NP_000446.1:p.Val338=
NP_000446.1:p.Val338=
NP_001394184.1:p.Val338=
LRG_319t1:c.1014G>A
LRG_319:g.38672G>A
LRG_319p1:p.Val338=
NC_000019.9:g.1223077G>A
NM_000455.4:c.1014G>A
NM_000455.4:c.1014G>A
NR_176325.1:n.2281G>A

Molecular consequence:

NR_176325.1:n.2281G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NM_000455.5:c.1014G>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001407255.1:c.1014G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:: Hereditary cancer-predisposing syndrome
Synonyms:: Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Mus musculus methionine sulfoxide reductase B1 (Msrb1), transcript variant 1, mR...
Mus musculus methionine sulfoxide reductase B1 (Msrb1), transcript variant 1, mRNA
gi|1090622382|ref|NM_013759.3|

Nucleotide
Homo sapiens phosphatidylinositol binding clathrin assembly protein (PICALM), Re...
Homo sapiens phosphatidylinositol binding clathrin assembly protein (PICALM), RefSeqGene on chromosome 11
gi|2301836725|ref|NG_028942.2|

Nucleotide
Component(Core) Links for Nucleotide (Select 1519314675) (2)
Nucleotide
MULTISPECIES: 30S ribosomal protein S3 [Enterobacterales]
MULTISPECIES: 30S ribosomal protein S3 [Enterobacterales]
gi|489009205|ref|WP_002919766.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004362414	Color Diagnostics, LLC DBA Color Health	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely benign (Nov 16, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV005165189	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Likely benign (Mar 30, 2024)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004362414

Color Diagnostics, LLC DBA Color Health

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely benign
(Nov 16, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005165189

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Likely benign
(Mar 30, 2024)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Color Diagnostics, LLC DBA Color Health, SCV004362414.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Ambry Genetics, SCV005165189.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 8, 2024

ClinVar

Relating variation to medicine